← Back to Search

Speech Entrainment for Aphasia

N/A

Recruiting

Led By Marja-Liisa Mailend, PhD

Research Sponsored by Albert Einstein Healthcare Network

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Between 18-80 years at the time of enrollment

English as native language

Must not have

History of other comorbid neurological impairments

Timeline

Screening 3 weeks

Treatment Varies

Follow Up one day post treatment

Awards & highlights

No Placebo-Only Group

Summary

This trial looks at how speech entrainment can help people speak more efficiently and effectively. It tracks informativeness and efficiency of speech to measure outcomes.

Who is the study for?

This trial is for English-speaking adults aged 18-80 with aphasia, which affects their ability to communicate. They must be more than six months post-onset and have a specific score on the Western Aphasia Battery - Revised test. Participants need to commit to multiple sessions either at the testing site or at home.

What is being tested?

The study tests two types of speech entrainment practices: audiovisual and auditory, to improve independent speech in people with aphasia. It measures how informative and efficient their speech is after treatment when telling stories.

What are the potential side effects?

Since this trial involves practice-based interventions rather than medication, traditional side effects are not expected. However, participants may experience fatigue or frustration during the exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 80 years old.

Select...

English is my first language.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a history of neurological problems.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ one day post treatment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~one day post treatment

This trial's timeline: 3 weeks for screening, Varies for treatment, and one day post treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Correct Information Units per Minute

Secondary study objectives

Number of Different Words per Minute

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Auditory Speech Entrainment PracticeExperimental Treatment2 Interventions

Auditory Speech Entrainment includes repeated practice of speaking synchronously with a recorded model, which provides contextual, temporal, and auditory cues for speaking.

Group II: Audiovisual Speech Entrainment PracticeExperimental Treatment2 Interventions

Audiovisual Speech Entrainment includes repeated practice of speaking synchronously with a recorded model, which provides contextual, temporal, and audiovisual cues for speaking.

0 / 3Eligibility criteria met